<DOC>
	<DOCNO>NCT00929968</DOCNO>
	<brief_summary>This study ass safety tolerability multiple dos VAK694 well change symptom biomarkers patient seasonal allergic rhinitis</brief_summary>
	<brief_title>Safety , Tolerability Pharmacokinetics Multiple Doses VAK694 Atopic Subjects With Seasonal Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Male female subject age 18 60 good health History atopy least 2 year positive skin prick test ragweed allergen Exclusion criterion : History asthma treat corticosteroid Smokers smoke history &gt; 10 pack/years smoke past year History chronic obstructive pulmonary disease Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Allergic rhinitis ,</keyword>
	<keyword>atopic patient ,</keyword>
	<keyword>seasonal allergy ,</keyword>
	<keyword>ragweed allergy</keyword>
</DOC>